EFDID: 491554EFD: View Filing

Issuer: ACELRX PHARMACEUTICALS INC (0001427925) - D

Accession: 0001427925-23-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001427925
  • Entity Name:
    ACELRX PHARMACEUTICALS INC
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    25821 INDUSTRIAL BOULEVARD
    SUITE 400
    HAYWARD, CA 94545
  • Persons:
    Related Persons 10
    Vincent J. Angotti
    Executive Officer, Director
    Pamela P. Palmer
    Director
    Raffi Asadorian
    Executive Officer
    Adrian Adams
    Director
    Richard Afable
    Director
    Jill Broadfoot
    Director
    Marina Bozilenko
    Director
    Stephen J. Hoffman
    Director
    Howard B. Rosen
    Director
    Mark Wan
    Director
EDGAR: Offering Information
  • Accession Date:
    07/28/2023
  • First Sale Date:
    07/17/2023
  • Offering Amount:
    $10,000,008
  • Amount Sold:
    $10,000,008
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CT, NC, NY
Inactive:IL, NV
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
H.C. Wainwright & Co., LLC 375 None None CT, IL, NV, NY, NC
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
ACELRX PHARMACEUTICALS INC/s/ Raffi AsadorianRaffi AsadorianChief Financial Officer2023-07-28